Vertex and Eli Lilly are revolutionizing non-opioid pain management with NaV1.8 advancements. See why I'm bullish about LLY ...

Patrick Gilligan, a former Blue Cross Blue Shield executive, will succeed Cain Hayes, who left the financially troubled ...

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

While employers aren’t yet reimbursing weight loss drugs en masse, significantly reduced net costs could affect their future ...